|
Protocol Number:
02-AT-0172
- Title:
A Randomized Study of Electroacupuncture Treatment for Delayed Chemotherapy-Induced Nausea and Vomiting in Patients with Pediatric Solid Tumors
- Number:
02-AT-0172
- Summary:
This study will examine the effectiveness of electroacupuncture in treating delayed nausea and vomiting after receiving chemotherapy for pediatric solid tumors. Studies have shown that acupuncture can help lessen nausea and vomiting on the days of chemotherapy, but delayed nausea and vomiting, occurring 1 to 5 days after chemotherapy, is sometimes more difficult to treat. Electroacupuncture, in which a small electric current is passed through the acupuncture needles, may provide a stronger effect than regular acupuncture, and lessen delayed nausea and vomiting.
Patients between 10 and 35 years of age with a newly diagnosed pediatric solid tumor who have not been treated with chemotherapy and have not previously had acupuncture may be eligible for this study.
- Sponsoring Institute:
-
National Center for Complementary and Alternative Medicine (NCCAM)
- Recruitment Detail
- Type:
Completed Study; data analyses ongoing
- Gender:
Male & Female
- Referral Letter Required:
No
- Population Exclusion(s):
None
- Eligibility Criteria:
This study is not currently recruiting new subjects. If you have questions about participating in a study, please contact the Patient Recruitment and Public Liaison Office, CC.
- Special Instructions:
Currently Not Provided
- Keyword(s):
-
Quality of Life
-
Stress
-
Sham Acupuncture
-
Acupuncture Points
-
Cancer Pain
-
Chemotherapy
-
Nausea and Vomiting
- Recruitment Keyword(s):
-
Acupuncture
-
Cancer
-
Pediatric Sarcoma
- Condition(s):
-
Pediatric Sarcoma
- Investigational Drug(s):
- None
- Investigational Device(s):
- None
- Interventions:
-
Procedure/Surgery: Electroacupuncture
- Supporting Site:
-
National Center for Complementary and Alternative Medicine
- Contact(s):
-
This study is not currently recruiting new subjects. If you have questions about participating in a study, please contact the Patient Recruitment and Public Liaison Office, CC.
- Citation(s):
-
Latreille J, Pater J, etc Use of dexamethasone and granisetron in the control of delayed emesis for patients who receive highly emetogenic chemotherapy National Cancer Instituteof Canada Clinical Trials Group J Clin Oncol 1998 Mar;16(3):1174-8
-
Morrow GR, Hickok JT, Burish TG, Rosenthal SN Frequency and clinical implications of delayed nausea and delayed emesisAm J Clin Oncol 1996 Apr;19(2):199-203
-
Stewart DA, Gyonyor E High-dose melphalan +/- total body irradiation and autologous hematopoietic stemcell rescue for adult patients with Ewing's sarcoma or peripheralneuroectodermal tumorBone Marrow Transplant 1996 Aug;18(2):315-8
If you have:
Search The Studies | Help | Questions | Clinical Center Home | NIH Home
National Institutes of Health Clinical Center
Bethesda, Maryland 20892. Last update: 01/30/2009
|
|